cancerous lesions. This can form very high medicinal concentration in the cancerous cells and thus it can have multiplying medicinal treatment effects. After the 4 week-course treatment, the patients’ prostate cancerous lesion scope can be significantly shrunk or completely disappear through MRI ...
The classification criteria for SD and PD were based on the RECIST 1.1 assessment. A patient is classified as having SD if the tumor has shrunk by < 30% and increased by < 20%, with no new lesions. PD is defined as an increase in the maximum diameter of the tumor by >...
In the United States, the nab-paclitaxel has been approved for the treatment of many solid tumors, including breast cancer, non-small-cell lung cancer, and pancreatic cancer.9 More investigations for the treatment of other solid tumors based on the nab-paclitaxel are ongoing. B...
Prostate-specific membrane antigen (PSMA) is a surface protein that is normally present on healthy prostate cells, but is found at much higher levels on prostate cancer cells. It is barely found in the rest of the body. "Therefore, PSMA is an ideal target for diagnostic purposes as well as...
The MCTS has particular interest in biomedical studies, especially in screening tests for cancer treatments, due to cellular 3D organization that mimics tumor tissues29,30. In this regard MCTS might include a proliferative, a quiescent and a necrotic layer, cell-to-cell communications channels, ...
cancer was found in his lungs. Rod’s oncologist explained that he could undergo surgery, chemotherapy or radiation, but none would really work with the type of cancer he had. “Basically, he told me to go home and enjoy the rest of my life. He gave me a card for the psychologist if...
Five years later, the 41-year-old mother of four has defied expectations: Her tumors have shrunk by half and doctors no longer are setting limits on her life expectancy. Duggan attributes her new hope to an unusual cancer treatment being tested at the University of Chicago -- the drug rapam...
for the treatment of prostate cancer. We confirmed that HF-PEF of 1800 V/cm, 100 μs width, 2 ms interval successfully decellularized the prostate tissue after 4 hours, and the tissues were almost regenerated in 28 days. IRE with HF-PEF has therapeutic potential to treat prostate cancer ...
radiation; prostate cancer; interleukin-12; T cell exhaustion; vascular maturation; liver toxicity1. Introduction Prostate cancer is the most common cancer to be diagnosed among men in the USA [1]. Radical prostatectomy and radiation therapy are the standard primary treatments for patients with ...
Therefore, there is an urgent need for new technical advances used to assist and improve cystoscopy. Urine cytology and biomarkers tests are routine methods for the diagnosis of bladder cancer. It is not only non-invasive and has high specificity for the detection of bladder cancer, but ...